A recent study of kinome profiling of breast cancer cell lines using unbiased multiplexed inhibitor beads (MIBs), mass spectrometry (MS) demonstrated that resistance to drugs that target PI3K components, including AKT and mTOR, was associated with a failure to inhibit AURKA. The gene discussed is PIK3CA; the disease is breast carcinoma.